Literature DB >> 7672683

Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis.

U Y Khoo1, I Bjarnason, A Donaghy, R Williams, A Macpherson.   

Abstract

It has been suggested that antibodies to a colonocyte protein of 40 kD (an intestinal isoform of tropomyosin) are specifically found in the serum and mucosa of patients with ulcerative colitis, which has important pathogenic implications. This study isolated and purified tropomyosin from the colonic mucosa, but no specific binding to this protein has been detected in serum samples or immunoglobulins isolated from mucosal washings of 20 ulcerative colitis (UC) patients by enzyme linked immunosorbent assay (ELISA) compared with 21 controls or 17 Crohn's disease (CD) patients. Samples from a further 12 patients with UC and primary sclerosing cholangitis (it is proposed that cross reactivity against the intestinal tropomyosin isoform accounts for the extraintestinal disease) also did not show binding to tropomyosin, whereas monoclonal antitropomyosin antisera bound both ELISAs and western blots. This study also examined the proteins in the normal colonic biopsy specimens on western blots that are bound by both serum samples and mucosal immunoglobulin preparations from these patients groups; there was no specific IgG or IgA binding to patients with UC or UC/primary sclerosing cholangitis, whereas binding to mitochondrial proteins of 70,000 and 45,000 was seen in samples from 12 primary biliary cirrhosis positive controls. This work does not support the hypothesis that autoimmune activity against the intestinal isoform or tropomyosin is important in the pathogenesis of ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672683      PMCID: PMC1382770          DOI: 10.1136/gut.37.1.63

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

Review 1.  [Is ulcerative colitis an autoimmune disease?].

Authors:  A Raedler; S Schreiber
Journal:  Dtsch Med Wochenschr       Date:  1992-08-28       Impact factor: 0.628

2.  Analytical subcellular fractionation of jejunal biopsy specimens: methodology and characterization of the organelles in normal tissue.

Authors:  T J Peters
Journal:  Clin Sci Mol Med       Date:  1976-12

3.  Autoantibodies to colonic cells and subcellular fractions in inflammatory bowel disease: do they exist?

Authors:  M Cantrell; T Prindiville; M E Gershwin
Journal:  J Autoimmun       Date:  1990-06       Impact factor: 7.094

4.  Serum and tissue autoantibodies to colonic epithelium in ulcerative colitis.

Authors:  K M Das
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

5.  Identification of the AraE transport protein of Escherichia coli.

Authors:  A J MacPherson; M C Jones-Mortimer; P J Henderson
Journal:  Biochem J       Date:  1981-04-15       Impact factor: 3.857

6.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

Authors:  H Malchow; K Ewe; J W Brandes; H Goebell; H Ehms; H Sommer; H Jesdinsky
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.

Authors:  M Oudkerk Pool; P M Ellerbroek; B U Ridwan; R Goldschmeding; B M von Blomberg; A S Peña; K M Dolman; H Bril; W Dekker; J J Nauta
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

9.  Immunological studies in ulcerative colitis. VIII. Antibodies to colon antigen in patients with ulcerative colitis, Crohn's disease, and other diseases.

Authors:  H E Carlsson; R Lagercrantz; P Perlmann
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

10.  Autoantibodies in human ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1959-11-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

3.  Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells.

Authors:  J C Lee; A M Cevallos; A Naeem; J E Lennard-Jones; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.

Authors:  E K Onuma; P S Amenta; K Ramaswamy; J J Lin; K M Das
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

5.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.